Ningxi Zhu

639 total citations
14 papers, 540 citations indexed

About

Ningxi Zhu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ningxi Zhu has authored 14 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Ningxi Zhu's work include Cell death mechanisms and regulation (6 papers), Cancer-related Molecular Pathways (6 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Ningxi Zhu is often cited by papers focused on Cell death mechanisms and regulation (6 papers), Cancer-related Molecular Pathways (6 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Ningxi Zhu collaborates with scholars based in United States, China and Canada. Ningxi Zhu's co-authors include Lubing Gu, Muxiang Zhou, Harry W. Findley, Hongying Zhang, Donald L. Durden, Yue Feng, Fengzhi Li, William G. Woods, Jin‐Tang Dong and Ceshi Chen and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Cell.

In The Last Decade

Ningxi Zhu

14 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ningxi Zhu United States	10	433	224	117	81	58	14	540
Ryosuke Moriai Japan	13	409 0.9×	216 1.0×	114 1.0×	107 1.3×	25 0.4×	15	616
Sophia X. Pfister United Kingdom	9	831 1.9×	216 1.0×	139 1.2×	57 0.7×	41 0.7×	11	959
Leslie Douglas United States	11	476 1.1×	176 0.8×	97 0.8×	114 1.4×	25 0.4×	13	589
Carol Swiderski United States	10	421 1.0×	291 1.3×	121 1.0×	86 1.1×	180 3.1×	13	650
Rongqing Pan United States	8	474 1.1×	190 0.8×	90 0.8×	113 1.4×	224 3.9×	21	679
Valérie Palissot Luxembourg	14	398 0.9×	99 0.4×	171 1.5×	73 0.9×	61 1.1×	22	567
Lilian Stärck Germany	8	337 0.8×	203 0.9×	50 0.4×	177 2.2×	25 0.4×	12	540
Xin Jing China	12	305 0.7×	173 0.8×	106 0.9×	135 1.7×	19 0.3×	28	554
Giulia Biondani Italy	9	283 0.7×	171 0.8×	182 1.6×	42 0.5×	35 0.6×	9	461
Christelle Dubey Switzerland	5	313 0.7×	127 0.6×	53 0.5×	48 0.6×	31 0.5×	10	428

Countries citing papers authored by Ningxi Zhu

Since Specialization

Citations

This map shows the geographic impact of Ningxi Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningxi Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningxi Zhu more than expected).

Fields of papers citing papers by Ningxi Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningxi Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningxi Zhu. The network helps show where Ningxi Zhu may publish in the future.

Co-authorship network of co-authors of Ningxi Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Ningxi Zhu. A scholar is included among the top collaborators of Ningxi Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ningxi Zhu. Ningxi Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Cui, Peng, et al.. (2019). <p>LncRNA RHPN1-AS1 Targeting miR-625/REG3A Promotes Cell Proliferation And Invasion Of Glioma Cells</p>. OncoTargets and Therapy. Volume 12. 7911–7921. 20 indexed citations

Gu, Lubing, Ningxi Zhu, Hongying Zhang, et al.. (2009). Regulation of XIAP Translation and Induction by MDM2 following Irradiation. Cancer Cell. 15(5). 363–375. 140 indexed citations

Gu, Lubing, et al.. (2008). Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells. BMC Cancer. 8(1). 69–69. 25 indexed citations

Zhu, Ningxi, Lubing Gu, Fengzhi Li, & Muxiang Zhou. (2008). Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells. Molecular Cancer Therapeutics. 7(5). 1101–1109. 39 indexed citations

Gu, Lubing, Kuang‐Yueh Chiang, Ningxi Zhu, Harry W. Findley, & Muxiang Zhou. (2007). Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines. Experimental Hematology. 35(6). 957–966. 29 indexed citations

Gu, Lubing, Ningxi Zhu, Harry W. Findley, & Muxiang Zhou. (2007). The MDM2 Antagonist Nutlin-3 Is a Potent Inducer of Apoptosis in Pediatric Acute Lymphoblastic Leukemia Cells with Wild-Type p53 and Overexpression of MDM2.. Blood. 110(11). 4277–4277. 2 indexed citations

Zhu, Ningxi, Lubing Gu, Harry W. Findley, et al.. (2006). KLF5 Interacts with p53 in Regulating Survivin Expression in Acute Lymphoblastic Leukemia. Journal of Biological Chemistry. 281(21). 14711–14718. 101 indexed citations

Zhu, Ningxi, et al.. (2005). Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53. Biochemical and Biophysical Research Communications. 335(4). 1272–1279. 28 indexed citations

Gu, Lubing, Harry W. Findley, Ningxi Zhu, & Muxiang Zhou. (2005). Endogenous TNFα Mediates Cell Survival and Chemotherapy Resistance by Activating the PI3K/Akt Pathway in Childhood Acute Lymphoblastic Leukemia.. Blood. 106(11). 4551–4551. 1 indexed citations

10.

Gu, Lubing, Ningxi Zhu, Harry W. Findley, & Muxiang Zhou. (2004). Loss of PTEN Expression Induces NF-kB Via PI3K/Akt Pathway Involving Resistance to Chemotherapy in Acute Lymphoblastic Leukemia Cell Lines.. Blood. 104(11). 4438–4438. 8 indexed citations

11.

Gu, Lubing, Ningxi Zhu, Harry W. Findley, William G. Woods, & Muxiang Zhou. (2004). Identification and Characterization of the IKKα Promoter. Journal of Biological Chemistry. 279(50). 52141–52149. 47 indexed citations

12.

Zhu, Ningxi, Lubing Gu, Harry W. Findley, Fengzhi Li, & Muxiang Zhou. (2004). An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy. Oncogene. 23(45). 7545–7551. 49 indexed citations

13.

Zhu, Ningxi, Lubing Gu, Harry W. Findley, Fengzhi Li, & Muxiang Zhou. (2004). An Alternatively Spliced Survivin Variant Is Positively Regulated by p53 and Sensitizes Leukemia Cells to Chemotherapy.. Blood. 104(11). 3497–3497. 3 indexed citations

14.

Zhou, Muxiang, Lubing Gu, Ningxi Zhu, William G. Woods, & Harry W. Findley. (2003). Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53. Oncogene. 22(50). 8137–8144. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact